Showing results (761-770 of 9,059) with videos related to
Sort By:
Pageof 906
Rheumatology (Oxford, England)|March 7, 2014
Increased phosphorylation of ezrin is associated with the migration and invasion of fibroblast-like synoviocytes from patients with rheumatoid arthritisYoujun Xiao, Mengying Sun, Zhongping Zhan, et al.Rheumatology (Oxford, England)|March 7, 2014
Identification of novel autoantibodies to GABA(B) receptors in patients with neuropsychiatric systemic lupus erythematosusHaruka Tsuchiya, Shiori Haga, Yuko Takahashi, et al.Rheumatology (Oxford, England)|March 7, 2014
Definition of improvement in juvenile idiopathic arthritis using the juvenile arthritis disease activity scoreGerd Horneff, Ingrid BeckerRheumatology (Oxford, England)|March 7, 2014
Pulmonary hypertension in systemic lupus erythematosus: echocardiography-based definitions predict 6-year survivalClaudia Hübbe-Tena, Selma Gallegos-Nava, Ricardo Márquez-Velasco, et al.Rheumatology (Oxford, England)|March 11, 2014
Induction treatment of ANCA-associated vasculitis with a single dose of rituximabTabitha Turner-Stokes, Eleanor Sandhu, Ruth J Pepper, et al.Rheumatology (Oxford, England)|March 15, 2014
Renal involvement in hypocomplementaemic urticarial vasculitis syndrome: a report of three paediatric casesAndrea Pasini, Claudia Bracaglia, Arianna Aceti, et al.Rheumatology (Oxford, England)|June 10, 2008
Association of markers of bone- and cartilage-degradation with radiological changes at baseline and after 2 years follow-up in patients with ankylosing spondylitisD Vosse, R Landewé, P Garnero, et al.Rheumatology (Oxford, England)|April 15, 2014
Symptom complexes in patients with seropositive arthralgia and in patients newly diagnosed with rheumatoid arthritis: a qualitative exploration of symptom developmentRebecca J Stack, Lilian H D van Tuyl, Maurits Sloots, et al.Rheumatology (Oxford, England)|April 15, 2014
Safety and efficacy of golimumab in Chinese patients with active ankylosing spondylitis: 1-year results of a multicentre, randomized, double-blind, placebo-controlled phase III trialChunde Bao, Feng Huang, Muhammad Asim Khan, et al.Rheumatology (Oxford, England)|April 15, 2014
Benefits and risks of low-dose glucocorticoid treatment in the patient with rheumatoid arthritisArthur Kavanaugh, Alvin F WellsPageof 906